Valuation: Ha Tay Pharmaceutical

Market Cap 5,371B 204M 179M 167M 153M 288M 19.76B 293M 1.99B 778M 9.64B 766M 750M 33.44B P/E 2024
109x
P/E 2025 109x
Enterprise Value 5,470B 208M 183M 170M 156M 293M 20.13B 298M 2.03B 792M 9.82B 780M 763M 34.06B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 week-4.66%
Current month-8.77%
1 month-8.20%
3 months-15.29%
6 months-16.48%
Current year-15.29%
1 week 58,000
Extreme 58000
65,200
1 month 58,000
Extreme 58000
66,000
Current year 58,000
Extreme 58000
75,800
1 year 58,000
Extreme 58000
86,800
3 years 17,090.91
Extreme 17090.9091
100,818.18
5 years 11,980.52
Extreme 11980.5195
100,818.18
10 years 4,801.26
Extreme 4801.2593
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2016
Corporate Officer/Principal - 01/03/2016
Corporate Officer/Principal 49 04/02/2015
Director TitleAgeSince
Chairman 75 01/01/2016
Director/Board Member 53 -
Director/Board Member 62 01/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.66%-23.26%+135.49% 204M
+1.97%+1.43%+48.44%+156.66% 1,057B
+1.42%+3.72%+53.32%+52.34% 624B
+1.43%+0.99%+34.83%+78.74% 454B
+0.36%+4.79%+32.10%+28.04% 341B
-0.84%+1.28%+35.36%+39.43% 297B
-0.47%+0.18%+15.69%+17.04% 262B
-0.30%-3.03%-28.44%-41.84% 215B
+1.49%-0.02%+20.14%+58.21% 201B
+0.40%-3.99%+15.23%+62.28% 162B
Average +0.44%+0.21%+20.34%+58.64% 361.42B
Weighted average by Cap. +0.80%+1.57%+34.93%+75.43%

Financials

2024 2025
Net sales 2,086B 79.27M 69.72M 64.77M 59.57M 112M 7.68B 114M 775M 302M 3.74B 298M 291M 12.99B 2,402B 91.27M 80.27M 74.57M 68.58M 129M 8.84B 131M 892M 348M 4.31B 343M 335M 14.96B
Net income 71.77B 2.73M 2.4M 2.23M 2.05M 3.84M 264M 3.91M 26.64M 10.39M 129M 10.24M 10.02M 447M 53.66B 2.04M 1.79M 1.67M 1.53M 2.87M 197M 2.92M 19.92M 7.77M 96.3M 7.65M 7.49M 334M
Net Debt 290B 11.02M 9.69M 9M 8.28M 15.52M 1.07B 15.8M 108M 41.98M 520M 41.35M 40.46M 1.81B 98.73B 3.75M 3.3M 3.06M 2.82M 5.29M 363M 5.38M 36.65M 14.3M 177M 14.08M 13.78M 615M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
23/07/26 ₫59,300.00 0.00% 1,300
22/07/26 ₫59,300.00 -0.50% 2,418
21/07/26 ₫59,600.00 -2.45% 4,310
20/07/26 ₫61,100.00 -1.93% 6,100
17/07/26 ₫62,300.00 +0.16% 15,100